Response to "clarification of enrolled subjects in tolvaptan HF trials"

Clin Pharmacol Ther. 2014 Dec;96(6):661. doi: 10.1038/clpt.2014.191. Epub 2014 Sep 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Antidiuretic Hormone Receptor Antagonists*
  • Arginine Vasopressin / antagonists & inhibitors*
  • Drug Design*
  • Heart Failure / drug therapy*
  • Humans

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Arginine Vasopressin